(Q61900317)

English

Phase II study of epirubicin and vinorelbine with granulocyte colony-stimulating factor: A high-activity, dose-dense weekly regimen for advanced breast cancer

scientific article published in August 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509155%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Phase II study of epirubicin and vinorelbine with granulocyte colony-stimulating factor: a high-activity, dose-dense weekly regimen for advanced breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509155%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Diana Giannarelli

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509155%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

C Nisticò

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509155%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

C Garufi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509155%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

S Barni

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509155%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

L Frontini

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509155%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

D A Gallà

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509155%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

A Vaccaro

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509155%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

A M D'Ottavio

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509155%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

E Terzoli

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509155%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 August 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509155%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509155%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509155%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509155%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

937-942

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509155%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Chemotherapy of breast cancer: current views and results.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008324329562

7 January 2021

based on heuristic

inferred from DOI database lookup

Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008324329562

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized comparison of single-agent doxorubicin and epirubicin as first-line cytotoxic therapy in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008324329562

7 January 2021

based on heuristic

inferred from DOI database lookup

Epirubicin treatment of advanced breast carcinoma with the weekly low-dose regimen

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008324329562

7 January 2021

based on heuristic

inferred from DOI database lookup

A weekly schedule of epirubicin in pretreated advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008324329562

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced cardiotoxicity of doxorubicin delivered on a weekly schedule. Assessment by endomyocardial biopsy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008324329562

7 January 2021

based on heuristic

inferred from DOI database lookup

Vinorelbine as first-line chemotherapy for metastatic breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008324329562

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of weekly IV vinorelbine in first-line advanced breast cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008324329562

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008324329562

7 January 2021

based on heuristic

inferred from DOI database lookup

Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008324329562

7 January 2021

based on heuristic

inferred from DOI database lookup

Vinorelbine: An active, non cross-resistant drug in advanced breast cancer. Results from a phase II study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008324329562

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008324329562

7 January 2021

based on heuristic

inferred from DOI database lookup

Vinorelbine neurotoxicity: clinical and neurophysiological findings in 23 patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008324329562

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008324329562

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of vinorelbine/doxorubicin as first-line therapy of advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008324329562

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008324329562

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008324329562

7 January 2021

based on heuristic

inferred from DOI database lookup

Vinorelbine and epirubicin in metastatic breast cancer. A dose finding study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008324329562

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-response effect of adjuvant chemotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008324329562

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid administration of multiple cycles of high-dose myelosuppressive chemotherapy in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008324329562

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008324329562

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509155%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509155%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q61900317&oldid=1448059765"